Intravitreal Long Acting Gas in the Prevention of Early Postoperative Vitreous Hemorrhage in Diabetic Vitrectomy
Condition(s):Diabetes Mellitus; Diabetic Retinopathy; Vitreous HemorrhageLast Updated:December 27, 2012Completed
Hide Studies Not Open or Pending
Condition(s):Diabetes Mellitus; Diabetic Retinopathy; Vitreous HemorrhageLast Updated:December 27, 2012Completed
Condition(s):Submacular Hemorrhage; Wet Macular Degeneration; Neovascular Age-related Macular DegenerationLast Updated:February 19, 2020Terminated
Condition(s):Vitreous Hemorrhage; Proliferative Diabetic RetinopathyLast Updated:April 26, 2013Completed
Condition(s):Proliferative Diabetic Retinopathy; Vitreous HemorrhageLast Updated:December 21, 2015Completed
Condition(s):Vitrectomy; Retinal Detachment; Vitreous Hemorrhage; Macular Holes; Epiretinal Membrane; Dislocated Intraocular Lens Into Vitreous; Retained Lens FragmentsLast Updated:June 4, 2021Unknown status
Condition(s):Proliferative Diabetic Retinopathy; Vitreous HemorrhageLast Updated:April 20, 2021Completed
Condition(s):Proliferative Diabetic RetinopathyLast Updated:November 29, 2016Unknown status
Condition(s):Proliferative Diabetic RetinopathyLast Updated:January 30, 2024Completed
Condition(s):Diabetic RetinopathyLast Updated:September 5, 2007Unknown status
Condition(s):Vitreous HemorrhageLast Updated:December 27, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.